CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zenith Drugs Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zenith Drugs Ltd
Depalpur
Na, Village Muradpura, K. No. 72/5
INDORE, 453001  India Ticker: ZENITHDRUGZENITHDRUG
Business Summary
Zenith Drugs Ltd is an India-based pharmaceutical manufacturing and trading company. The Company manufactures and trades pharmaceuticals, drugs enzymes and sanitary napkins and all classes of chemicals used for manufacture of the aforesaid and all other kinds of chemicals and their by-products intermediates, derivatives, formulations, and compounds. It offers a range of formulations in various forms, such as ORS powder, liquid orals, ointments, liquid externals, and capsules. Its liquid orals products include Iron & Folic Acid Syrup IP, Hungrykop Syrup, BIozen Multivitamin Syrup, Rexkop DX Syrup, and Zoomol Plus Syrup. Its ointment products include Clobetol GM Cream, Painfree Gel, POVIZ M Ointment, and Candizen Cream. Its liquid external section products include Poviz Solutin (Lotion), Bioscaby Lotion, Permethirn Lotion, Gamma Benzene Hexachloride 1% Lotion, and Scabikop Lotion. Its capsule section products include Pyvoxee Spas Plus Capsule, BIO-Omi Capsule, and Lopagen Capsule.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20233/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8742 Management consulting services

General Information
Outstanding Shares: 17,148,800 (As of 9/30/2023)
Stock Exchange: NSE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, May 2, 2024